Can Imirzalioglu
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.5%
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 40
-
- Escherichia coli research studies 9
- Enterobacteriaceae and Cronobacter Research 8
- Co-authors
- Trinad Chakraborty (49 shared papers)Stephen E. Mshana (14 shared papers)Linda Falgenhauer (34 shared papers)Eugen Domann (20 shared papers)Torsten Hain (21 shared papers)Moritz Fritzenwanker (18 shared papers)Mariam M. Mirambo (5 shared papers)Martha F. Mushi (3 shared papers)
- Journals
- Frontiers in Microbiology (7 papers)Journal of Clinical Microbiology (5 papers)BMC Infectious Diseases (5 papers)International Journal of Antimicrobial Agents (3 papers)BMC Microbiology (3 papers)
- Partner nations
- GermanyTanzaniaSwitzerland
In The Last Decade
Can Imirzalioglu
76 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 119
- Molecular Medicine 1.5k
- Endocrinology 691
- Applied Microbiology and Biotechnology 195
- Pollution 590
- Clinical Biochemistry 226
Countries citing papers authored by Can Imirzalioglu
This map shows the geographic impact of Can Imirzalioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Imirzalioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Imirzalioglu more than expected).
Fields of papers citing papers by Can Imirzalioglu
This network shows the impact of papers produced by Can Imirzalioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Imirzalioglu. The network helps show where Can Imirzalioglu may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Imirzalioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 193 | |
| 2 | 2011 | 152 | |
| 3 | 2003 | 148 | |
| 4 | 2014 | 131 | |
| 5 | 2019 | 127 | |
| 6 | 2014 | 121 | |
| 7 | 2014 | 112 | |
| 8 | 2013 | 101 | |
| 9 | 2018 | 99 | |
| 10 | 2017 | 78 | |
| 11 | 2016 | 75 | |
| 12 | 2011 | 74 | |
| 13 | 2020 | 73 | |
| 14 | 2016 | 72 | |
| 15 | 2013 | 71 | |
| 16 | 2008 | 68 | |
| 17 | 2018 | 68 | |
| 18 | 2016 | 66 | |
| 19 | 2009 | 59 | |
| 20 | 2017 | 56 |
About Can Imirzalioglu
Can Imirzalioglu is a scholar working on Molecular Medicine, Endocrinology, Epidemiology, Molecular Biology and Infectious Diseases, having authored 77 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (40 papers), Escherichia coli research studies (9 papers), Enterobacteriaceae and Cronobacter Research (8 papers), Pharmaceutical and Antibiotic Environmental Impacts (8 papers), Urinary Tract Infections Management (7 papers), Genomics and Phylogenetic Studies (7 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Gut microbiota and health (5 papers). The work is most often cited by research in Molecular Medicine (1.5k citations), Endocrinology (691 citations), Applied Microbiology and Biotechnology (195 citations), Pollution (590 citations) and Clinical Biochemistry (226 citations). Can Imirzalioglu has collaborated with scholars based in Germany, Tanzania and Switzerland. Frequent co-authors include Trinad Chakraborty, Stephen E. Mshana, Linda Falgenhauer, Eugen Domann, Torsten Hain, Moritz Fritzenwanker, Mariam M. Mirambo, Martha F. Mushi, Yancheng Yao and William Mahalu. Their work appears in journals such as Frontiers in Microbiology, Journal of Clinical Microbiology, BMC Infectious Diseases, International Journal of Antimicrobial Agents and BMC Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.